Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch
- 1 October 2018
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 550 (1-2) , 71-78
Abstract
No abstract availableKeywords
Funding Information
- Georgia Research Alliance (GRA.VL17.11)
- National Institute on Drug Abuse (DA12970)
This publication has 20 references indexed in Scilit:
- Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): A study of Daytrana™ methylphenidate transdermal systemDrug Development and Industrial Pharmacy, 2011
- Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studiesAnnals of the New York Academy of Sciences, 2010
- Approaches to the development of medications for the treatment of methamphetamine dependenceAddiction, 2007
- Treatment Strategies for Co‐Occurring ADHD and Substance Use DisordersThe American Journal on Addictions, 2007
- Medication Development for Addictive Disorders: The State of the ScienceAmerican Journal of Psychiatry, 2005
- Development of a Rationally Designed, Low Abuse Potential, Biogenic Amine Releaser That Suppresses Cocaine Self-AdministrationThe Journal of Pharmacology and Experimental Therapeutics, 2005
- The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychological Medicine, 2005
- Drug addiction: the neurobiology of behaviour gone awryNature Reviews Neuroscience, 2004
- Agonist-like, replacement pharmacotherapy for stimulant abuse and dependenceAddictive Behaviors, 2004
- The viscoelastic properties of natural rubber pressure‐sensitive adhesive using acrylic resin as a tackifierJournal of Applied Polymer Science, 2003